Abbott beats quarterly profit estimates on strong medical device sales
The company now expects a full-year profit of $4.55 to $4.70 per share, raising the lower end from $4.50 per share. Analysts were expecting a profit of $4.60 per share.
Abbott Laboratories beat Wall Street estimates for quarterly profit on Wednesday and raised the lower end of its forecast, as robust demand for medical procedures boosted sales of its devices, including its glucose-monitoring products.
On an adjusted basis, the company reported first-quarter profit of 98 cents per share, compared with analysts' estimate of 95 cents per share, according to LSEG data.
The company now expects a full-year profit of $4.55 to $4.70 per share, raising the lower end from $4.50 per share. Analysts were expecting a profit of $4.60 per share.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.